Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
06/2000
06/14/2000EP1007563A1 Hm74a receptor
06/14/2000EP1007552A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
06/14/2000EP1007539A1 Secreted proteins and polynucleotides encoding them
06/14/2000EP1007522A1 2- 4-[4-(4, 5-dichloro -2-methylimidazol-1-yl) butyl]-1-piperazinyl -5-fluoropyrimidine,preparation and therapeutic use
06/14/2000EP1007512A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors
06/14/2000EP1007093A1 Methods for treating disorders by using interleukin-9 and its antagonists
06/14/2000EP1007069A1 Novel coding sequences
06/14/2000EP1007056A1 Method for the treatment of cystic fibrosis
06/14/2000EP1007047A1 Use of mizolastine for preparing a medicine for treating inflammation
06/14/2000EP1007046A1 Method for treatment of chronic bronchitis
06/14/2000EP1007033A1 Lymphocyte function antigen-1 antagonists
06/14/2000EP1007017A1 New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof
06/14/2000EP1007008A1 Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol
06/14/2000EP1007002A1 Lipid-containing compositions and uses thereof
06/14/2000EP0901463B1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
06/14/2000CN1053366C Chinese herbal lotion and its prepn.
06/13/2000US6075054 Antiarrhythmic pharmaceuticals having a cardioprotective component for infarct prophylaxis and infarct treatment as well as for the treatment of angina pectoris
06/13/2000US6075048 Administering to the child a higher dose, as measured on a mg/kg basis, of bambuterol, or of a pharmaceutically acceptable salt thereof, than the adult dose of bambuterol; for treatment of asthma
06/13/2000US6075038 Alpha 1a adrenergic receptor antagonists
06/13/2000US6075006 For treatment of arthritis, asthma, inflammation, tumoral growth, gastro intestinal hypermotility, huntington disease, neuritis, neuralgia, migraine, hypertension, incontinence of urine, urticaria, symptoms of the carcinoid syndrome
06/13/2000CA2125667C Fluorocarbon aerosol medicaments
06/13/2000CA2107014C Therapeutic agent for parkinson's disease
06/13/2000CA1341023C Peptide derivatives
06/08/2000WO2000032766A1 Human vanilloid receptors and their uses
06/08/2000WO2000032600A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives
06/08/2000WO2000032587A1 Sf2809-i, ii, iii, iv, v and vi substances exhibiting chymase-inhibiting activities
06/08/2000WO2000032584A2 Nonsteroidal antiinflammatories
06/08/2000WO2000032575A1 β-ALANINE DERIVATIVES AS α4 INTEGRIN INHIBITORS
06/08/2000WO2000032570A1 Hydrazine derivatives
06/08/2000WO2000032217A1 Small peptides and methods for treatment of asthma and inflammation
06/08/2000WO2000032216A1 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
06/08/2000WO2000032189A1 Celecoxib compositions
06/08/2000WO2000032165A1 Milling process for the production of finely milled medicinal substances
06/08/2000WO2000018386A3 Antibiotic compositions for treatment of the eye, ear and nose
06/08/2000WO2000015245A3 Stable liquid formulations of botulinum toxin
06/08/2000WO2000004137A9 Human aspartic proteases
06/08/2000CA2353550A1 Small peptides and methods for treatment of asthma and inflammation
06/08/2000CA2352367A1 Nonsteroidal antiinflammatories
06/08/2000CA2351321A1 Hydrazine derivatives
06/08/2000CA2347701A1 .beta.-alanine derivatives as .alpha.4 integrin inhibitors
06/08/2000CA2342621A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives
06/07/2000EP1005867A2 Botulinum toxins for modulating cholinergic controlled secretions
06/07/2000EP1005860A1 Non-chlorofluorocarbon aerosol formulations
06/07/2000EP1005485A1 Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage
06/07/2000EP1005480A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
06/07/2000EP1005471A1 Pyrazolo(3,4-d)pyrimidines with anticonvulsive and antiallergic/antiasthmatic action
06/07/2000EP1005446A1 N-aroylphenylalanine derivatives
06/07/2000EP1005445A1 N-alkanoylphenylalanine derivatives
06/07/2000EP1005345A1 Methods and compositions for treating allergic asthma and other disorders using descarboethoxyloratadine
06/07/2000EP1005341A1 Il-8 receptor antagonists
06/07/2000EP1005332A2 Pharmaceutical composition for reducing production of mcp-1 protein
06/07/2000EP1005328A1 Composition comprising finely divided, crystalline particles of budesonide
06/07/2000EP0840606B1 Di- and trivalent small molecule selectin inhibitors
06/07/2000CN1255862A Use of avian antibodies
06/07/2000CN1255350A Classification and prescriptions for five symptons of chronic pharyngitis
06/07/2000CN1255343A Buccal lozenge of boat sterculia seed for preventing and curing acute and chronic inflammation of upper respiratory tract
06/06/2000US6072032 Amino acid sequence of polypeptide involved in protein secretory apparatus of bacteria; for screening for bactericides and bacteriostats; diagnosis of and prophylaxis for infections
06/06/2000US6072029 Derivatives of human α1 -antitrypsin and process for their preparation
06/06/2000US6071971 For treating pulmonary disorders
06/06/2000US6071968 Phenylenediamine derivative radical scavenger, brain-infarction depressant, and brain-edema depressant
06/06/2000US6071938 Benzopyrans
06/06/2000US6071894 Sensor histidine kinase of Staphylococcus aureus
06/06/2000US6071722 Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
06/06/2000US6071523 Oral administering from squeezable container; storage stability, heat resistance; drug delivery
06/02/2000WO2000031280A2 Use of plus-strand synthesis elements in retroviral vectors
06/02/2000WO2000031263A2 Gtpase associated proteins
06/02/2000WO2000031113A1 INTRACELLULAR TARGETED DELIVERY OF COMPOUNDS BY 70 kD HEAT SHOCK PROTEIN
06/02/2000WO2000031109A1 USE OF CORE 2 GlcNAc TRANSFERASE INHIBITORS IN TREATING INFLAMMATION
06/02/2000WO2000031100A2 Benzylmaltosides as inhibitors of smooth muscle cell proliferation
06/02/2000WO2000031095A2 Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
06/02/2000WO2000031094A2 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
06/02/2000WO2000031093A2 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
06/02/2000WO2000031083A1 Phospholipid derivatives of non-steroidal anti-inflammatory drugs
06/02/2000WO2000031065A1 Compounds having cytokine inhibitory activity
06/02/2000WO2000031063A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
06/02/2000WO2000031060A1 Scavenger compounds
06/02/2000WO2000031054A1 Il-5 inhibiting 6-azauracil derivatives
06/02/2000WO2000031053A1 Il-5 inhibiting 6-azauracil derivatives
06/02/2000WO2000031049A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
06/02/2000WO2000031047A1 Substituted 4-amino-2-aryl-cyclopenta[d]pyrimidines, their production and use and pharmaceuticalreparations containing same
06/02/2000WO2000031038A1 Quinoline derivatives as nk-2 and nk-3 receptor ligands
06/02/2000WO2000031037A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
06/02/2000WO2000031033A1 Piperidine ccr-3 receptor antagonists
06/02/2000WO2000031032A1 Pyrrolidine derivatives-ccr-3 receptor antagonists
06/02/2000WO2000030681A1 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases
06/02/2000WO2000030664A1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of pulmonary diseases
06/02/2000WO2000030654A1 Anti-asthmatic combinations comprising surface active phospholipids
06/02/2000WO2000030633A1 Method of treating chronic obstructive pulmonary disease
06/02/2000WO2000030614A1 A process for producing particles with a converted amorphous and/or meta-stable crystalline region into crystalline state
06/02/2000WO2000030613A1 New process
06/02/2000WO2000030607A1 PHARMACEUTICAL AEROSOL COMPOSITION CONTAINING HFA 227 AND HFA 134a
06/02/2000WO2000018388A3 Antibiotic compositions for treatment of the eye, ear and nose
06/02/2000WO2000013703A9 Methods of treating hypertension and compositions for use therein
06/02/2000CA2352963A1 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases
06/02/2000CA2352583A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
06/02/2000CA2352543A1 Method of treating chronic obstructive pulmonary disease
06/02/2000CA2352338A1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of pulmonary diseases
06/02/2000CA2352144A1 Scavenger compounds
06/02/2000CA2351865A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
06/02/2000CA2351725A1 Substituted pyrazoles as p38 kinase inhibitors
1 ... 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 ... 878